Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.
The U.S. labor market faced its toughest year since the pandemic in 2025, with layoffs soaring to 1.2 million. Economists warn of an 'uncomfortably slow' rebound in 2026, leaving job seekers navigating a landscape of fierce competition and hiring freezes.
The Norwegian Nobel Committee has concluded that a pre-announcement leak of the 2025 Peace Prize laureate's name was likely the result of digital espionage, raising serious questions about the security of the prestigious award and the motives behind the breach.
Ark Invest's Cathie Wood suggests the recent historic rally in gold may be a late-cycle bubble, pointing to valuation metrics that have surpassed levels seen in the 1930s. The warning follows a sharp, cross-market sell-off that dragged down precious metals and cryptocurrencies.
The Union Solidarity and Development Party (USDP), backed by Myanmar's military, has secured a commanding majority in the country's protracted general election, a result widely anticipated but condemned by critics as a sham designed to cement junta control.
Three men face felony charges following a viral New Year's shooting from a Dallas overpass, with investigators linking suspects to a separate road-rage attack and uncovering a cache of firearms.
New analysis from NRC Health reveals that integrating real-time patient sentiment tools like Net Promoter Score with traditional HCAHPS surveys can accelerate improvements in care quality and directly impact Medicare reimbursements under value-based programs.
Becton Dickinson announces a major spin-off of its Biosciences unit to combine with Waters Corporation, alongside a successful pilot to recycle polystyrene labware, signaling a dual push towards portfolio focus and sustainability.
Shares and bonds of New World Development surged after reports that Blackstone is in advanced talks to become its largest shareholder, a potential lifeline for the embattled Hong Kong property giant and a signal of shifting sentiment in the city's real estate market.
Calix reports historic 2025 financial results, surpassing $1 billion in annual revenue, while outlining its strategic pivot to a third-generation 'Agent Workforce' platform and capitalizing on a projected multi-billion dollar BEAD program opportunity.
As Sempra (NYSE: SRE) navigates a massive capital investment cycle for grid modernization and clean energy, investors are scrutinizing whether its current stock price accurately reflects its long-term strategy. We analyze key valuation metrics and the broader market context to assess if the utility giant is fairly valued.
From under a dollar to over three, the price of a dozen eggs tells a story of inflation, disease, and changing agriculture. We break down the real cost by decade and explore what's driving your grocery bill higher.
York Space Systems (YSS) launched onto the public market with a strong first-day pop, capitalizing on defense spending trends and a push for scalable satellite manufacturing. Yet, its path is fraught with competition and the financial growing pains typical of a capital-intensive industry.
The Hong Kong Monetary Authority (HKMA) is poised to grant its inaugural stablecoin issuer licenses next month, a key step in the city's comprehensive push to establish a regulated digital asset ecosystem. The move follows a rigorous application process and signals a new era of oversight for the burgeoning sector.
The benchmark index has been trapped in a tight range for months, gaining a mere 1% since October as a defensive rotation into energy and healthcare pressures tech-heavy portfolios. Analysts warn the prolonged consolidation is creating a 'ticking clock' scenario, setting the stage for a decisive breakout or breakdown.
DaVita Inc. shares soared after the kidney care provider posted robust fourth-quarter results and issued a 2026 profit forecast that significantly exceeded Wall Street expectations, signaling resilience against cost pressures and past operational challenges.
A dominant institutional ownership of Nanosonics Limited brings both stability risks and concentrated power dynamics, as analysts weigh the stock's future trajectory in the infection prevention market.
As stock markets cool from years of stellar gains, a disciplined rebalancing is underway. Vanguard data reveals a broad-based move into fixed income, signaling a strategic pivot rather than panic.
Caterpillar, the industrial titan, rode the AI infrastructure wave to become the top-performing Dow stock in 2025. With record earnings on the horizon, investors are asking if its momentum can defy high valuations and continue into the new year.
In a stark New Year's address, German Chancellor Friedrich Merz warned that Europe faces an 'epochal break' in global order and must urgently strengthen its strategic autonomy, economic competitiveness, and defense capabilities to navigate rising geopolitical tensions.
